The influence of LSD on locomotor activity in reserpinized mice.
D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D002090:Butyrophenones / Q000494:pharmacology; D003533:Cyproheptadine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects; D012110:Reserpine / Q000008:administration & dosage*; D013141:Spiro Compounds / Q000494:pharmacology
D000081:Acetamides; D001565:Benzoates; D002090:Butyrophenones; D010880:Piperidines; D011955:Receptors, Drug; D013141:Spiro Compounds; D010643:Phenoxybenzamine; D010868:Pimozide; D003533:Cyproheptadine; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D006220:Haloperidol; D008784:Methysergide